Tobira Therapeutics Inc  

(Public, NASDAQ:TBRA)   Watch this stock  
Find more results for Carol J. Cooper´┐Ż
12.30
+0.47 (3.97%)
Sep 4 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 11.62 - 12.30
52 week 7.20 - 24.31
Open 11.73
Vol / Avg. 29,862.00/81,057.00
Mkt cap 135.02M
P/E     -
Div/yield     -
EPS -1.44
Shares 17.44M
Beta     -
Inst. own 0%
Aug 11, 2015
Q2 2015 Tobira Therapeutics Inc Earnings Call - Webcast
Aug 11, 2015
Q2 2015 Tobira Therapeutics Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -153.93% -234.93%
Return on average equity - -
Employees 11 -
CDP Score - -

Address

701 Gateway Blvd Ste 300
SOUTH SAN FRANCISCO, CA 94080-7412
United States - Map
+1-650-7416625 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Tobira Therapeutics, Inc., formerly Regado BioSciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular indications. As of December 31, 2014, the operations of Regado had been terminated and as such the required business controls have been reduced. The Company has a subsidiary, Regado Biosciences Europe Limited. As of December 31, 2014, Regado Biosciences Europe Limited had no operations.

Officers and directors

Dennis G. Podlesak Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Laurent Fischer M.D. Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Christopher Peetz Chief Financial Officer
Age: 36
Bio & Compensation  - Reuters
Helen Jenkins Chief Operating Officer
Age: 51
Bio & Compensation  - Reuters
Ian Clements Ph.D. Vice President of Investor Relations and Corporate Communications
Bio & Compensation  - Reuters
Eric Lefebvre M.D. Chief Medical Officer
Age: 51
Bio & Compensation  - Reuters
Carol L. Brosgart M.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Jeffrey H. Cooper CPA Independent Director
Age: 59
Bio & Compensation  - Reuters
Andrew J. Fromkin Independent Director
Age: 48
Bio & Compensation  - Reuters
Patrick J. Heron Independent Director
Age: 44
Bio & Compensation  - Reuters